Psychedelic-Assisted Psychotherapy PAT

Emerging evidence

What it is

Combines psychotherapy with a psychedelic substance, such as psilocybin, MDMA or ketamine, taken in a supervised setting. The substance is thought to open a window where difficult material can be processed more easily with a therapist's support.

Typical lengthVaries; often a few dosing sessions plus prep and integration
FormatIndividual, in a clinic or research setting
HomeworkLight, reflection

May suit you if

  • Depression or PTSD has not responded to other treatment
  • You can join a clinical trial or a licensed ketamine program

Keep in mind

  • Still investigational; the FDA declined to approve MDMA-assisted therapy in 2024
  • Not for people with a history of psychosis, and never something to try on your own

How treatment works

Usually there are preparation sessions, one or more long dosing sessions with trained staff present, and integration sessions afterward to make sense of the experience. In the US, psilocybin and MDMA are still in research trials; ketamine and the nasal spray esketamine are legally available through medical clinics.

History & Founding
The founder
Many contributors
Psychiatrists, psychologists and researchers

Psychedelic therapy has many contributors rather than one founder. Early researchers studied LSD in psychiatry in the 1950s and 1960s. In recent decades, scientists such as Roland Griffiths at Johns Hopkins and organizations like MAPS, founded by Rick Doblin, revived careful research into psilocybin and MDMA.

The historyEst. 1950s · Europe and North America

After LSD was discovered, psychiatrists in Europe and North America studied it for alcoholism, depression and end-of-life distress. By the late 1960s and early 1970s, political backlash and new drug laws largely halted the research. Starting around 2000, new studies at universities reopened the field under strict rules. Esketamine, a form of ketamine, was approved for treatment-resistant depression in 2019. In 2024 the FDA declined to approve MDMA-assisted therapy for PTSD, and psilocybin trials are still ongoing.

In crisis? Call or text 988 (Suicide & Crisis Lifeline) or go to the nearest emergency room.